Related references
Note: Only part of the references are listed.Epigenetic Therapeutics: A New Weapon in the War Against Cancer
Nita Ahuja et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases
Michael H. Irwin et al.
DRUG DEVELOPMENT RESEARCH (2016)
Clinical Experience With Deferiprone Treatment for Friedreich Ataxia
Sandra Elincx-Benizri et al.
JOURNAL OF CHILD NEUROLOGY (2016)
Reversal of epigenetic promoter silencing in Friedreich ataxia by a class I histone deacetylase inhibitor
Yogesh K. Chutake et al.
NUCLEIC ACIDS RESEARCH (2016)
Activating frataxin expression by repeat-targeted nucleic acids
Liande Li et al.
NATURE COMMUNICATIONS (2016)
Iron-sulfur cluster biogenesis in mammalian cells: New insights into the molecular mechanisms of cluster delivery
Nunziata Maio et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Src inhibitors modulate frataxin protein levels
Fabio Cherubini et al.
HUMAN MOLECULAR GENETICS (2015)
Mechanism of action of 2-aminobenzamide HDAC inhibitors in reversing gene silencing in Friedreich's ataxia
Elisabetta Soragni et al.
FRONTIERS IN NEUROLOGY (2015)
FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia
Yogesh K. Chutake et al.
PLOS ONE (2015)
Epigenetic Therapy for Friedreich Ataxia
Elisabetta Soragni et al.
ANNALS OF NEUROLOGY (2014)
Epigenetic Promoter Silencing in Friedreich Ataxia is Dependent on Repeat Length
Yogesh K. Chutake et al.
ANNALS OF NEUROLOGY (2014)
Histone variants: key players of chromatin
Burcu Biterge et al.
CELL AND TISSUE RESEARCH (2014)
Therapeutic approaches for the treatment of Friedreich's ataxia
Cassandra J. Strawser et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia
Sunil Sahdeo et al.
HUMAN MOLECULAR GENETICS (2014)
Altered Nucleosome Positioning at the Transcription Start Site and Deficient Transcriptional Initiation in Friedreich Ataxia
Yogesh K. Chutake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Quantitative Proteomic Analysis Identifies Targets and Pathways of a 2-Aminobenzamide HDAC Inhibitor in Friedreich's Ataxia Patient iPSC-Derived Neural Stem Cells
Bing Shan et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study
Vincenzo Libri et al.
LANCET (2014)
Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia
Morgane Perdomini et al.
NATURE MEDICINE (2014)
Pathophysiogical and therapeutic progress in Friedreich ataxia
H. Puccio et al.
REVUE NEUROLOGIQUE (2014)
R-loops Associated with Triplet Repeat Expansions Promote Gene Silencing in Friedreich Ataxia and Fragile X Syndrome
Matthias Groh et al.
PLOS GENETICS (2014)
Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation
Alain Martelli et al.
FRONTIERS IN PHARMACOLOGY (2014)
Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database
Guenther Metz et al.
BRAIN (2013)
Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreichs ataxia can be reduced upon HDAC inhibition by vitamin B3
Ping K. Chan et al.
HUMAN MOLECULAR GENETICS (2013)
Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
Benjamin E. L. Lauffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Gene regulation and epigenetics in Friedreich's ataxia
Cihangir Yandim et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Co-enzyme Q10 and idebenone use in Friedreich's ataxia
Michael H. Parkinson et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Frataxin: a protein in search for a function
Annalisa Pastore et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Deferiprone for the treatment of Friedreich's ataxia
Massimo Pandolfo et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Transcriptional regulation by Polycomb group proteins
Luciano Di Croce et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Development of Frataxin Gene Expression Measures for the Evaluation of Experimental Treatments in Friedreich's Ataxia
Heather L. Plasterer et al.
PLOS ONE (2013)
HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner
Melissa Malvaez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A TAT-Frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model
Piyush M. Vyas et al.
HUMAN MOLECULAR GENETICS (2012)
Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model
Barbara Tomassini et al.
HUMAN MOLECULAR GENETICS (2012)
Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors as Therapeutics for Friedreich Ataxia
Elisabetta Soragni et al.
JOURNAL OF CHILD NEUROLOGY (2012)
Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
Haiqun Jia et al.
NEUROBIOLOGY OF DISEASE (2012)
Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo
Maria Beconi et al.
PLOS ONE (2012)
Histone Deacetylase Complexes Promote Trinucleotide Repeat Expansions
Kim Debacker et al.
PLOS BIOLOGY (2012)
A gene expression phenotype in lymphocytes from friedreich ataxia patients
Giovanni Coppola et al.
ANNALS OF NEUROLOGY (2011)
Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia
Alessandra Rufini et al.
HUMAN MOLECULAR GENETICS (2011)
Repeat Expansion Affects Both Transcription Initiation and Elongation in Friedreich Ataxia Cells
Daman Kumari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mortality in Friedreich Ataxia
Amy Y. Tsou et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2011)
Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
Chiranjeevi Sandi et al.
NEUROBIOLOGY OF DISEASE (2011)
Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich's ataxia
Eunah Kim et al.
NUCLEIC ACIDS RESEARCH (2011)
Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich's Ataxia: A New Synthetic Route
Chunping Xu et al.
PHARMACEUTICALS (2011)
Long intronic GAA repeats causing Friedreich ataxia impede transcription elongation
Tanel Punga et al.
EMBO MOLECULAR MEDICINE (2010)
Chemical phylogenetics of histone deacetylases
James E. Bradner et al.
NATURE CHEMICAL BIOLOGY (2010)
Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model
Myriam Rai et al.
PLOS ONE (2010)
Chemical Probes Identify a Role for Histone Deacetylase 3 in Friedreich's Ataxia Gene Silencing
Chunping Xu et al.
CHEMISTRY & BIOLOGY (2009)
Epigenetic Silencing in Friedreich Ataxia Is Associated with Depletion of CTCF (CCCTC-Binding Factor) and Antisense Transcription
Irene De Biase et al.
PLOS ONE (2009)
Progressive GAA.TTC Repeat Expansion in Human Cell Lines
Scott Ditch et al.
PLOS GENETICS (2009)
Influence of Friedreich ataxia GAA noncoding repeat expansions on pre-mRNA processing
Marco Baralle et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)
Joey L. Methot et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Recombinant Human Erythropoietin Increases Frataxin Protein Expression Without Increasing mRNA Expression
Fabio Acquaviva et al.
CEREBELLUM (2008)
DNA triplexes and Friedreich ataxia
Robert D. Wells
FASEB JOURNAL (2008)
Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases
C. James Chou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Chemical probes for histone-modifying enzymes
Philip A. Cole
NATURE CHEMICAL BIOLOGY (2008)
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Aleksey G. Kazantsev et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model
Myriam Rai et al.
PLOS ONE (2008)
In vivo imaging of pyrrole-imidazole polyamides with positron emission tomography
Daniel A. Harki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues
Sahar Al-Mahdawi et al.
HUMAN MOLECULAR GENETICS (2008)
SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation
Alejandro Vaquero et al.
NATURE (2007)
Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group
Thomas Beckers et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia
Eriko Greene et al.
NUCLEIC ACIDS RESEARCH (2007)
Activity-based probes for proteomic profiling of histone deacetylase complexes
Cleo M. Salisbury et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia
David Herman et al.
NATURE CHEMICAL BIOLOGY (2006)
Mechanism-based profiling of enzyme families
Michael J. Evans et al.
CHEMICAL REVIEWS (2006)
DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA•TTC repeats in Friedreich's ataxia
Ryan Burnett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1
AD Napper et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Therapeutics development for triplet repeat expansion diseases
NA Di Prospero et al.
NATURE REVIEWS GENETICS (2005)
DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing
A Saveliev et al.
NATURE (2003)
Sticky DNA, a self-associated complex formed at long GAA•TTC repeats in intron 1 of the frataxin gene, inhibits transcriptions
N Sakamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Alleviating transcript insufficiency caused by Friedreich's ataxia triplet repeats
E Grabczyk et al.
NUCLEIC ACIDS RESEARCH (2000)
The GAA•TTC triplet repeat expanded in Friedreich's ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner
E Grabczyk et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
